Globus Ev To Sales vs Capex To Revenue Analysis

GMED Stock

USD 81.78 1.64 1.97%

Globus Medical financial indicator trend analysis is much more than just examining Globus Medical latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Globus Medical is a good investment. Please check the relationship between Globus Medical Ev To Sales and its Capex To Revenue accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Ev To Sales vs Capex To Revenue

Ev To Sales vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Globus Medical Ev To Sales account and Capex To Revenue. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Globus Medical's Ev To Sales and Capex To Revenue is 0.17. Overlapping area represents the amount of variation of Ev To Sales that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Globus Medical, assuming nothing else is changed. The correlation between historical values of Globus Medical's Ev To Sales and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Sales of Globus Medical are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Ev To Sales i.e., Globus Medical's Ev To Sales and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.17

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Globus Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.The current year's Selling General Administrative is expected to grow to about 675.6 M, whereas Tax Provision is forecasted to decline to about 34.9 M.

	2021	2022	2023	2024 (projected)
Gross Profit	718.9M	759.1M	1.0B	533.4M
Total Revenue	958.1M	1.0B	1.6B	1.6B

Gross Profit Total Revenue

Globus Medical fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets
Common Stock Shares Outstanding		0.7	0.49	0.63	0.69	0.73	0.7	0.68	0.72	0.27	0.83	0.76	0.54	0.69	0.54	0.55	0.9	0.68	0.99	0.53	0.65	0.75	0.58	0.59	0.66	0.74
Total Assets	0.7		0.93	0.96	0.99	1.0	0.84	1.0	0.79	0.67	0.58	0.96	0.93	1.0	0.81	0.59	0.67	1.0	0.71	0.95	0.99	0.99	0.98	0.97	0.98	1.0
Short Long Term Debt Total	0.49	0.93		0.95	0.95	0.91	0.67	0.94	0.61	0.82	0.26	0.88	0.92	0.94	0.68	0.4	0.4	0.95	0.52	1.0	0.96	0.89	0.99	0.99	0.9	0.92
Other Current Liab	0.63	0.96	0.95		0.98	0.95	0.83	0.96	0.73	0.77	0.44	0.92	0.88	0.96	0.72	0.55	0.6	0.96	0.66	0.97	0.97	0.93	0.97	0.98	0.95	0.96
Total Current Liabilities	0.69	0.99	0.95	0.98		0.99	0.83	0.99	0.77	0.73	0.53	0.96	0.91	0.99	0.76	0.55	0.63	0.99	0.71	0.97	0.99	0.98	0.99	0.98	0.97	0.99
Total Stockholder Equity	0.73	1.0	0.91	0.95	0.99		0.86	0.99	0.81	0.63	0.63	0.96	0.92	1.0	0.83	0.62	0.7	0.99	0.73	0.93	0.99	0.99	0.96	0.96	0.98	1.0
Other Liab	0.7	0.84	0.67	0.83	0.83	0.86		0.82	0.9	0.42	0.71	0.79	0.71	0.83	0.67	0.66	0.78	0.81	0.7	0.73	0.82	0.83	0.77	0.77	0.9	0.86
Property Plant And Equipment Net	0.68	1.0	0.94	0.96	0.99	0.99	0.82		0.77	0.68	0.56	0.95	0.93	1.0	0.82	0.59	0.65	1.0	0.69	0.96	0.99	0.99	0.98	0.98	0.97	0.99
Current Deferred Revenue	0.72	0.79	0.61	0.73	0.77	0.81	0.9	0.77		0.31	0.78	0.75	0.69	0.78	0.72	0.63	0.83	0.77	0.71	0.66	0.77	0.79	0.71	0.7	0.85	0.8
Net Debt	0.27	0.67	0.82	0.77	0.73	0.63	0.42	0.68	0.31		-0.03	0.68	0.53	0.67	0.29	0.02	0.14	0.7	0.32	0.8	0.71	0.61	0.76	0.78	0.64	0.66
Retained Earnings	0.83	0.58	0.26	0.44	0.53	0.63	0.71	0.56	0.78	-0.03		0.61	0.41	0.57	0.64	0.66	0.93	0.55	0.79	0.31	0.5	0.65	0.41	0.39	0.59	0.6
Accounts Payable	0.76	0.96	0.88	0.92	0.96	0.96	0.79	0.95	0.75	0.68	0.61		0.83	0.95	0.77	0.51	0.68	0.97	0.77	0.89	0.95	0.96	0.93	0.92	0.94	0.97
Cash	0.54	0.93	0.92	0.88	0.91	0.92	0.71	0.93	0.69	0.53	0.41	0.83		0.93	0.81	0.58	0.5	0.92	0.55	0.93	0.94	0.9	0.94	0.93	0.89	0.91
Non Current Assets Total	0.69	1.0	0.94	0.96	0.99	1.0	0.83	1.0	0.78	0.67	0.57	0.95	0.93		0.81	0.58	0.65	1.0	0.69	0.96	0.99	0.99	0.98	0.98	0.98	0.99
Non Currrent Assets Other	0.54	0.81	0.68	0.72	0.76	0.83	0.67	0.82	0.72	0.29	0.64	0.77	0.81	0.81		0.7	0.67	0.81	0.54	0.7	0.78	0.85	0.75	0.73	0.81	0.8
Other Assets	0.55	0.59	0.4	0.55	0.55	0.62	0.66	0.59	0.63	0.02	0.66	0.51	0.58	0.58	0.7		0.72	0.55	0.54	0.44	0.56	0.64	0.49	0.48	0.55	0.61
Cash And Short Term Investments	0.9	0.67	0.4	0.6	0.63	0.7	0.78	0.65	0.83	0.14	0.93	0.68	0.5	0.65	0.67	0.72		0.63	0.88	0.45	0.6	0.71	0.52	0.52	0.67	0.7
Net Receivables	0.68	1.0	0.95	0.96	0.99	0.99	0.81	1.0	0.77	0.7	0.55	0.97	0.92	1.0	0.81	0.55	0.63		0.69	0.96	0.99	0.98	0.98	0.98	0.97	0.99
Common Stock Total Equity	0.99	0.71	0.52	0.66	0.71	0.73	0.7	0.69	0.71	0.32	0.79	0.77	0.55	0.69	0.54	0.54	0.88	0.69		0.56	0.66	0.75	0.61	0.61	0.67	0.74
Non Current Liabilities Total	0.53	0.95	1.0	0.97	0.97	0.93	0.73	0.96	0.66	0.8	0.31	0.89	0.93	0.96	0.7	0.44	0.45	0.96	0.56		0.98	0.91	0.99	1.0	0.92	0.94
Inventory	0.65	0.99	0.96	0.97	0.99	0.99	0.82	0.99	0.77	0.71	0.5	0.95	0.94	0.99	0.78	0.56	0.6	0.99	0.66	0.98		0.97	0.99	0.99	0.97	0.99
Other Current Assets	0.75	0.99	0.89	0.93	0.98	0.99	0.83	0.99	0.79	0.61	0.65	0.96	0.9	0.99	0.85	0.64	0.71	0.98	0.75	0.91	0.97		0.95	0.94	0.96	0.99
Other Stockholder Equity	0.58	0.98	0.99	0.97	0.99	0.96	0.77	0.98	0.71	0.76	0.41	0.93	0.94	0.98	0.75	0.49	0.52	0.98	0.61	0.99	0.99	0.95		1.0	0.95	0.97
Total Liab	0.59	0.97	0.99	0.98	0.98	0.96	0.77	0.98	0.7	0.78	0.39	0.92	0.93	0.98	0.73	0.48	0.52	0.98	0.61	1.0	0.99	0.94	1.0		0.95	0.96
Property Plant And Equipment Gross	0.66	0.98	0.9	0.95	0.97	0.98	0.9	0.97	0.85	0.64	0.59	0.94	0.89	0.98	0.81	0.55	0.67	0.97	0.67	0.92	0.97	0.96	0.95	0.95		0.98
Total Current Assets	0.74	1.0	0.92	0.96	0.99	1.0	0.86	0.99	0.8	0.66	0.6	0.97	0.91	0.99	0.8	0.61	0.7	0.99	0.74	0.94	0.99	0.99	0.97	0.96	0.98

Click cells to compare fundamentals

Globus Medical Account Relationship Matchups

High Positive Relationship

Total Stockholder Equity	+ 1.0	Total Assets
Property Plant And Equipment Net	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Net Receivables	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total

High Negative Relationship

Retained Earnings

- 0.03

Net Debt

Globus Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	102.0M	101.0M	103.6M	102.6M	114.6M	104.1M
Total Assets	1.5B	1.7B	2.0B	2.1B	5.1B	5.3B
Other Current Liab	6.7M	93.4M	105.1M	105.5M	301.5M	316.6M
Total Current Liabilities	111.4M	120.8M	140.2M	159.2M	392.3M	412.0M
Total Stockholder Equity	1.4B	1.5B	1.7B	1.8B	4.0B	4.2B
Other Liab	17.1M	52.4M	75.7M	70.5M	81.1M	85.2M
Property Plant And Equipment Net	199.8M	216.9M	221.1M	243.7M	646.9M	679.2M
Current Deferred Revenue	5.4M	8.1M	12.0M	14.1M	18.4M	9.6M
Net Debt	(193.2M)	(234.6M)	(188.0M)	(144.5M)	53.1M	55.8M
Retained Earnings	1.0B	1.0B	1.2B	1.2B	1.1B	764.6M
Accounts Payable	24.6M	18.2M	22.0M	36.1M	56.7M	59.5M
Cash	195.7M	239.4M	193.1M	150.5M	467.3M	490.7M
Non Current Assets Total	844.6M	857.7M	1.1B	1.1B	3.2B	3.3B
Non Currrent Assets Other	21.7M	32.0M	36.3M	43.3M	78.6M	82.5M
Other Assets	25.2M	209.8M	60.8M	92.2M	106.0M	111.3M
Cash And Short Term Investments	311.5M	426.7M	443.4M	446.1M	517.8M	342.9M
Net Receivables	162.4M	148.1M	165.7M	217.3M	504.9M	530.1M
Liabilities And Stockholders Equity	1.5B	1.7B	2.0B	2.1B	5.1B	5.3B
Non Current Liabilities Total	18.2M	52.4M	75.7M	70.5M	695.8M	730.6M
Inventory	196.3M	229.2M	237.0M	299.0M	848.1M	890.5M
Other Current Assets	17.2M	17.8M	18.4M	21.0M	44.6M	46.8M
Other Stockholder Equity	357.3M	457.2M	553.8M	631.0M	2.9B	3.0B
Total Liab	129.6M	173.2M	215.9M	229.8M	1.1B	1.1B
Property Plant And Equipment Gross	199.8M	216.9M	526.7M	586.8M	1.1B	1.1B
Total Current Assets	687.5M	821.8M	864.5M	983.3M	1.9B	2.0B
Accumulated Other Comprehensive Income	(2.9M)	4.0M	(6.8M)	(24.6M)	(10.2M)	(9.7M)
Short Term Debt	74.7M	88.7M	94.4M	2.5M	12.0M	11.4M
Property Plant Equipment	202.3M	216.9M	221.1M	243.7M	280.3M	146.5M
Good Will	128.8M	156.7M	179.7M	197.5M	1.4B	1.5B
Intangible Assets	78.8M	86.9M	68.7M	63.6M	924.6M	970.8M
Net Tangible Assets	1.2B	1.3B	1.5B	1.6B	1.8B	981.4M
Short Term Investments	115.8M	187.3M	250.4M	295.6M	50.5M	48.0M
Capital Surpluse	357.3M	457.2M	553.8M	631.0M	725.6M	761.9M
Non Current Liabilities Other	12.2M	46.2M	71.4M	68.8M	102.9M	108.1M
Long Term Investments	409.5M	358.5M	562.5M	495.9M	75.4M	71.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:

How To Invest In Globus

Details

Is Globus Stock a good investment?

Details

What is Globus Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

42.231

Earnings Share

0.62

Revenue Per Share

18.217

Quarterly Revenue Growth

0.631

Return On Assets

0.0473

The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Globus Ev To Sales vs Capex To Revenue Analysis

Ev To Sales vs Capex To Revenue

Ev To Sales vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Ev To Sales

Capex To Revenue

Globus Medical fundamental ratios Correlations

Globus Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Globus Medical fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY